- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03024203
A Comparison of Cognitive Training Approaches in Psychotic Disorders
November 12, 2018 updated by: Dr. Christopher Bowie, Queen's University
Cognitive remediation (CR) is the best treatment to improve neurocognitive abilities for individuals with psychosis, however, there is no gold standard method of cognitive remediation available.
Cognitive training refers to the training component of CR in which people practice computerized exercises that train specific cognitive abilities.
There is no agreed upon approach within the field as to the type of training that is most effective with some studies, training higher level cognitive abilities, some training perceptual abilities, and others training general cognitive skills.
This study will directly compare two competing methods of cognitive training on measures of neurophysiology, neurocognition, functional competence, and real-world functional performance.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Kingston, Ontario, Canada, K7L 5P6
- Queen's University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- psychotic disorder
- No previous cognitive remediation in past 6 months
Exclusion Criteria:
- Brain injury
- Substance abuse
- Neurocognitive disorder
- Developmental Disability
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Executive Training
Executive Training (ET) involves training on computerized cognitive exercises that have graded increases in difficulty so that the participant is always challenged.
A therapist will be in the room with participants to address any difficulties with the program and facilitate generation of strategies.
ET will be delivered in both individual and group settings.
|
Cognitive remediation is a cognitive and behavioural therapy designed to improve cognitive skills such as memory, and problem solving ability.
|
|
Experimental: Perceptual Training
Perceptual Training (PT) involves training on computerized cognitive exercises that have graded increases in difficulty so that the participant is always challenged.
A therapist will be in the room with participants to address any difficulties with the program and facilitate generation of strategies.
PT will be delivered in both individual and group settings.
|
Cognitive remediation is a cognitive and behavioural therapy designed to improve cognitive skills such as attention, and processing speed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Functional Performance - Specific Levels of Functioning (SLOF) from Baseline
Time Frame: Post-treatment (within 2 weeks following the end of treatment)
|
Rating scale completed by participants' case managers that rates their ability to perform different everyday tasks
|
Post-treatment (within 2 weeks following the end of treatment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Neurocognition - MATRICS Cognitive Consensus Battery (MCCB) from Baseline
Time Frame: Post-treatment (within 2 weeks following the end of treatment)
|
The MCCB is the gold standard cognitive assessment for schizophrenia research
|
Post-treatment (within 2 weeks following the end of treatment)
|
|
Change in Neurophysiology - EEG from Baseline
Time Frame: Post-treatment (within 2 weeks following the end of treatment)
|
Alpha and Theta band synchronization, p300, mismatch negativity
|
Post-treatment (within 2 weeks following the end of treatment)
|
|
Functional Competence - Canadian Objective Assessment of Life Skills Brief (COALS-B) from Baseline
Time Frame: Post-treatment (within 2 weeks following the end of treatment)
|
Performance based measure of real life functional skills using role-play
|
Post-treatment (within 2 weeks following the end of treatment)
|
|
Change in Functional Performance - Specific Levels of Functioning (SLOF) from Baseline
Time Frame: Follow-Up (3 months after the end of treatment)
|
Rating scale completed by participants' case managers that rates their ability to perform different everyday tasks
|
Follow-Up (3 months after the end of treatment)
|
|
Change in Neurocognition - MATRICS Cognitive Consensus Battery (MCCB) from Baseline
Time Frame: Follow-Up (3 months after the end of treatment)
|
The MCCB is the gold standard cognitive assessment for schizophrenia research
|
Follow-Up (3 months after the end of treatment)
|
|
Change in Neurophysiology - EEG from Baseline
Time Frame: Follow-Up (3 months after the end of treatment)
|
Alpha and Theta band synchronization, p300, mismatch negativity
|
Follow-Up (3 months after the end of treatment)
|
|
Functional Competence - Canadian Objective Assessment of Life Skills Brief (COALS-B) from Baseline
Time Frame: Follow-Up (3 months after the end of treatment)
|
Performance based measure of real life functional skills using role-play
|
Follow-Up (3 months after the end of treatment)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2016
Primary Completion (Actual)
March 1, 2018
Study Completion (Actual)
March 1, 2018
Study Registration Dates
First Submitted
October 27, 2016
First Submitted That Met QC Criteria
January 15, 2017
First Posted (Estimate)
January 18, 2017
Study Record Updates
Last Update Posted (Actual)
November 14, 2018
Last Update Submitted That Met QC Criteria
November 12, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PSYC-173-16
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychotic Disorders
-
Medical College of WisconsinCompletedSchizophrenia | Affective Disorders | Psychotic Disorder | Psychotic Mood Disorder
-
Søren Dinesen ØstergaardCompletedAffective Disorders, PsychoticDenmark
-
Instituto de Investigación Hospital Universitario...Carlos III Health Institute; European Regional Development FundCompletedSchizophrenia and Disorders With Psychotic Features | Psychotic EpisodeSpain
-
Instituto de Investigación Hospital Universitario...CompletedSchizophrenia and Disorders With Psychotic Feature | Psychotic EpisodeSpain
-
Centre hospitalier de Ville-Evrard, FranceRecruiting
-
University Hospital, Strasbourg, FranceRecruiting
-
University of California, San DiegoCompletedSchizophrenia | Schizoaffective Disorder | Mood Disorder, PsychoticUnited States
-
University of MinnesotaUniversity of California, San FranciscoCompletedPsychotic Disorders | Schizophrenia | Schizoaffective Disorder | Cognitive Impairment | Psychosis | Treatment | Psychotic Depression | Psychotic Episode | Active Control | Psychotic Mood DisordersUnited States
-
Boston Medical CenterNational Institute of Mental Health (NIMH); Beth Israel Deaconess Medical CenterCompletedPsychotic Disorders | Psychosis | Psychotic EpisodeUnited States
-
Natalia Dewi Wardani, MDIndonesian Red Cross; The Indonesian Red CrossCompleted
Clinical Trials on Cognitive Remediation - Executive Training
-
University of TorontoOntario Shores Centre for Mental Health SciencesWithdrawnSchizophrenia | Schizophrenia and Related Disorders | Schizophrenia Spectrum DisorderCanada
-
Fundació Sant Joan de DéuCompletedIndication for Modification of Patient Cognitive StatusSpain
-
University of Alabama at BirminghamRecruitingCognitive Impairment | Sickle Cell Disease | Self Efficacy | Coping Skills | Health-Related Behavior | Adolescent BehaviorUnited States
-
UConn HealthNational Institute of Mental Health (NIMH)CompletedDepressive Disorder, Major | Mild Cognitive Impairment | Depression MildUnited States
-
Yale UniversityCompletedCancer | Cancer of the ProstateUnited States
-
Science and Research Centre KoperAlbert Einstein College of Medicine; University of Primorska; Vrije Universiteit...CompletedEffects of Cognitive Intervention on Cognition, Mobility and Brain Electrocortical Activity (GIBKOP)Cognitive Impairment | Aging | Cognitive Decline | Motor Coordination or FunctionSlovenia
-
Douglas Mental Health University InstituteMcGill University; Canadian Institutes of Health Research (CIHR)Recruiting
-
Hospital Clinic of BarcelonaInstituto de Salud Carlos III; Centro de Investigación Biomédica en Red de...Completed
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Centre for Addiction and Mental HealthCompleted